TAK-418
brain-penetrant LSD1 inh. for neuro. disorders sociability improvement in vivo, completed Ph. I in HV tranylcypromine class mechanism-based inh. Sci. Adv., Mar. 12, 2021 Takeda Pharmaceuticals, Fujisawa, JP
Molecules of the Month - March 2021
Molecules of the Month
- LSN3318839
- GLPG1972
- APJ compound 14
- encequidar
- S62798 (Servier)
- CVN424
- ABBV-167
- GDC-0310
- "compound 72"
- "compound 20"
- TAK-418
- compound 13 (GSK716)
- RBN-012759
- sisunatovir